BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 19448045)

  • 1. Slowly digestible carbohydrate sources can be used to attenuate the postprandial glycemic response to the ingestion of diabetes-specific enteral formulas.
    Vanschoonbeek K; Lansink M; van Laere KM; Senden JM; Verdijk LB; van Loon LJ
    Diabetes Educ; 2009; 35(4):631-40. PubMed ID: 19448045
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of two carbohydrate-modified tube-feeding formulas on metabolic responses in patients with type 2 diabetes.
    Voss AC; Maki KC; Garvey WT; Hustead DS; Alish C; Fix B; Mustad VA
    Nutrition; 2008 Oct; 24(10):990-7. PubMed ID: 18718737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A diabetes-specific enteral formula improves glycemic variability in patients with type 2 diabetes.
    Alish CJ; Garvey WT; Maki KC; Sacks GS; Hustead DS; Hegazi RA; Mustad VA
    Diabetes Technol Ther; 2010 Jun; 12(6):419-25. PubMed ID: 20470226
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-fat versus high-carbohydrate enteral formulae: effect on blood glucose, C-peptide, and ketones in patients with type 2 diabetes treated with insulin or sulfonylurea.
    Sanz-París A; Calvo L; Guallard A; Salazar I; Albero R
    Nutrition; 1998; 14(11-12):840-5. PubMed ID: 9834926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Very high-protein and low-carbohydrate enteral nutrition formula and plasma glucose control in adults with type 2 diabetes mellitus: a randomized crossover trial.
    Huhmann MB; Yamamoto S; Neutel JM; Cohen SS; Ochoa Gautier JB
    Nutr Diabetes; 2018 Aug; 8(1):45. PubMed ID: 30158516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of glucose elevation after simulated tube feeding with a low-carbohydrate, high-fat enteral formula in patients with type I diabetes.
    Peters AL; Davidson MB; Isaac RM
    Am J Med; 1989 Aug; 87(2):178-82. PubMed ID: 2502921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glycemic Effects of a Low-Carbohydrate Enteral Formula Compared With an Enteral Formula of Standard Composition in Critically Ill Patients: An Open-Label Randomized Controlled Clinical Trial.
    van Steen SC; Rijkenberg S; Sechterberger MK; DeVries JH; van der Voort PHJ
    JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):1035-1045. PubMed ID: 30133840
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glycemic response to dietary supplements in cystic fibrosis is dependent on the carbohydrate content of the formula.
    Milla C; Doherty L; Raatz S; Schwarzenberg SJ; Regelmann W; Moran A
    JPEN J Parenter Enteral Nutr; 1996; 20(3):182-6. PubMed ID: 8776690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Methodology of use of an enteral nutrition formulas in diet therapy of patients with type 2 diabetes].
    Sharafetdinov KhKh; Meshcheriakova VA; Plotnikova OA
    Vopr Pitan; 2005; 74(4):17-22. PubMed ID: 16265910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced glycaemic and insulinaemic responses following isomaltulose ingestion: implications for postprandial substrate use.
    van Can JG; Ijzerman TH; van Loon LJ; Brouns F; Blaak EE
    Br J Nutr; 2009 Nov; 102(10):1408-13. PubMed ID: 19671200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes-specific enteral nutrition formula in hyperglycemic, mechanically ventilated, critically ill patients: a prospective, open-label, blind-randomized, multicenter study.
    Mesejo A; Montejo-González JC; Vaquerizo-Alonso C; Lobo-Tamer G; Zabarte-Martinez M; Herrero-Meseguer JI; Acosta-Escribano J; Blesa-Malpica A; Martinez-Lozano F
    Crit Care; 2015 Nov; 19():390. PubMed ID: 26549276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemic and lipid control in hospitalized type 2 diabetic patients: evaluation of 2 enteral nutrition formulas (low carbohydrate-high monounsaturated fat vs high carbohydrate).
    León-Sanz M; García-Luna PP; Sanz-París A; Gómez-Candela C; Casimiro C; Chamorro J; Pereira-Cunill JL; Martin-Palmero A; Trallero R; Martínez J; Ordóñez FJ; García-Peris P; Camarero E; Gómez-Enterría P; Cabrerizo L; Perez-de-la-Cruz A; Sánchez C; García-de-Lorenzo A; Rodríguez N; Usán L;
    JPEN J Parenter Enteral Nutr; 2005; 29(1):21-9. PubMed ID: 15715270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved Glucose Profile in Patients With Type 2 Diabetes With a New, High-Protein, Diabetes-Specific Tube Feed During 4 Hours of Continuous Feeding.
    Lansink M; Hofman Z; Genovese S; Rouws CHFC; Ceriello A
    JPEN J Parenter Enteral Nutr; 2017 Aug; 41(6):968-975. PubMed ID: 26826263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of short-term low- and high-carbohydrate diets on postprandial metabolism in non-diabetic and diabetic subjects.
    Culling KS; Neil HA; Gilbert M; Frayn KN
    Nutr Metab Cardiovasc Dis; 2009 Jun; 19(5):345-51. PubMed ID: 18083355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of dietary carbohydrate, fat, and protein on postprandial glycemia and energy intake in cats.
    Farrow HA; Rand JS; Morton JM; O'Leary CA; Sunvold GD
    J Vet Intern Med; 2013; 27(5):1121-35. PubMed ID: 23869495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of breakfast meal composition on second meal metabolic responses in adults with Type 2 diabetes mellitus.
    Clark CA; Gardiner J; McBurney MI; Anderson S; Weatherspoon LJ; Henry DN; Hord NG
    Eur J Clin Nutr; 2006 Sep; 60(9):1122-9. PubMed ID: 16670695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Administration of a new diabetes-specific enteral formula results in an improved 24h glucose profile in type 2 diabetic patients.
    Ceriello A; Lansink M; Rouws CH; van Laere KM; Frost GS
    Diabetes Res Clin Pract; 2009 Jun; 84(3):259-66. PubMed ID: 19307037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of fat on gastric emptying of and the glycemic, insulin, and incretin responses to a carbohydrate meal in type 2 diabetes.
    Gentilcore D; Chaikomin R; Jones KL; Russo A; Feinle-Bisset C; Wishart JM; Rayner CK; Horowitz M
    J Clin Endocrinol Metab; 2006 Jun; 91(6):2062-7. PubMed ID: 16537685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A three-day insulin-induced normoglycemia improves carbohydrate oxidation in type 2 diabetic subjects.
    Rigalleau V; Rabemanantsoa C; Gin H
    Metabolism; 2002 Nov; 51(11):1484-8. PubMed ID: 12404202
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.